Newsfeeds - Spark Newswire

3 minute read

Clever Leaves Reports Third Quarter 2021 Results, Continues Expansion

Today, 11:57 AM

Clever Leaves Holdings Inc. (NASDAQ: CLVR) (NASDAQ: CLVRW), a leading multinational operator and licensed producer of pharmaceutical-grade cannabinoids reported its financial and operating results for the third quarter ended Septe

CLVR

1 minute read

Clever Leaves Holdings Q3 EPS $0.04 Beats $(0.40) Estimate, Sales $4.03M Miss $4.55M Estimate

By Benzinga Newsdesk

Today, 11:57 AM

Clever Leaves Holdings (NASDAQ:CLVR) reported quarterly earnings of $0.04 per share which beat the analyst consensus estimate of $(0.40) by 110 percent. This is a 108.33 percent increase over losses of $(0.48) per share

CLVR

18 minute read

Earnings Scheduled For November 10, 2021

By Benzinga Insights

Today, 11:57 AM

Companies Reporting Before The Bell • LumiraDx (NASDAQ:LMDX) is projected to report quarterly loss at $0.24 per share on revenue of $94.32 million.

AACG

9 minute read

The Week In Cannabis: Canopy’s Earnings, JPMorgan’s Restrictions, A Slew Of Earnings, Big Policy Moves

By Javier Hasse

Today, 11:57 AM

Below is a recap of the main news related to the cannabis industry and markets for the week of November 1st, 2021. Contents

AFCG

2 minute read

EXCLUSIVE: Brazilian Regulators Approve CBD Medication, University To Study Its Effectiveness Against Long-Haul COVID-19

By Javier Hasse

Today, 11:57 AM

In a major regulatory win for the entire cannabis industry, the stringent Brazilian Health Regulatory Agency (Anvisa) has approved a cannabis-derived CBD 50 mg/ml product produced by Verdemed Pharmaceuticals, in partnership with Colombian-American operator Clever Leaves Holdings Inc (NASDAQ:

CLVR

3 minute read

International Spotlight – Continued Cannabis Expansion in European Markets

By Nicolas Jose Rodriguez

Today, 11:57 AM

During Benzinga Cannabis Capital Conference, several leaders of various cannabis companies gathered to discuss the continuous expansion of the cannabis market outside the U.S.

ACB

2 minute read

Clever Leaves Reports Partnership With Pharmalab PHL Labs To Provide Patients With Medical Cannabis, No Terms Disclosed

By Benzinga Newsdesk

Today, 11:57 AM

Clever Leaves Holdings Inc. (NASDAQ:CLVR, CLVRW)) (“Clever Leaves” or the “Company”), a leading multinational operator and licensed producer of pharmaceutical-grade cannabinoids, announced the

CLVR

2 minute read

Clever Leaves Confirms Its First Commercial Export Of THC Flower From Portugal To The U.S.

By Nina Zdinjak

Today, 11:57 AM

Clever Leaves Holdings Inc. (NASDAQ: CLVR) confirmed Wednesday that it will export 30 kg of high-THC cannabis flower from its Portugal facility to the Biopharmaceutical Research Company (“BRC”), a DEA-licensed pharmaceutical company.

CLVR

2 minute read

Clever Leaves Highlights Exported 30 kg Of High-THC Cannabis Flower From Its Portugal Facility To Biopharma Research Co.

By Benzinga Newsdesk

Today, 11:57 AM

CLVR

4 minute read

Clever Leaves is Advancing Research into Cannabis for Chronic Disease Treatment with “Project Change Lives”

By Ernest Dela Aglanu

Today, 11:57 AM

Image Provided by Clever Leaves For years, cannabinoids, the chemicals found in the cannabis plant, have been widely known for their therapeutic and medicinal abilities.

CLVR